§ Funding Round
Series B funding round for Amal Therapeutics raising $33M in November 2018
Series B funding round for Amal Therapeutics raising $33M in November 2018
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
Boehringer IngelheimLEAD | — | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$46M
Top Valuation
-
Amal Therapeutics raised $33M in a Series B round.
The round was announced on 11/01/18.
The round was led by Boehringer Ingelheim.
